RBP4 and coronary artery disorder: In the ACS group, the prevalence of RBP-4 ≥4 ng/ml, LCI ≥16, RBP-4 ≥4 ng/ml + LCI ≥16 were significantly higher than non-CAD group (all p < 0.05).